Susquehanna International Group’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.76M Buy
126,023
+16,039
+15% +$224K ﹤0.01% 2446
2025
Q1
$1.48M Buy
109,984
+14,119
+15% +$190K ﹤0.01% 2717
2024
Q4
$1.84M Buy
95,865
+19,956
+26% +$383K ﹤0.01% 2098
2024
Q3
$1.73M Buy
75,909
+26,698
+54% +$607K ﹤0.01% 2005
2024
Q2
$640K Sell
49,211
-5,229
-10% -$68K ﹤0.01% 3162
2024
Q1
$953K Buy
54,440
+29,122
+115% +$510K ﹤0.01% 2712
2023
Q4
$551K Sell
25,318
-6,329
-20% -$138K ﹤0.01% 3716
2023
Q3
$485K Sell
31,647
-178,349
-85% -$2.74M ﹤0.01% 3446
2023
Q2
$5M Buy
209,996
+117,670
+127% +$2.8M ﹤0.01% 1145
2023
Q1
$2.35M Buy
92,326
+76,822
+495% +$1.95M ﹤0.01% 1785
2022
Q4
$453K Sell
15,504
-8,782
-36% -$257K ﹤0.01% 3361
2022
Q3
$498K Sell
24,286
-62,968
-72% -$1.29M ﹤0.01% 3550
2022
Q2
$1.01M Sell
87,254
-10,273
-11% -$119K ﹤0.01% 2447
2022
Q1
$1.8M Buy
+97,527
New +$1.8M ﹤0.01% 2125
2021
Q4
Hold
0
6499
2021
Q3
Hold
0
6145
2020
Q2
Sell
-3,014
Closed -$20K 4993
2020
Q1
$20K Buy
+3,014
New +$20K ﹤0.01% 4350
2019
Q3
Sell
-747
Closed -$23K 5073
2019
Q2
$23K Buy
+747
New +$23K ﹤0.01% 4350
2017
Q2
Sell
-946
Closed -$177K 4416
2017
Q1
$177K Buy
+946
New +$177K ﹤0.01% 2868
2016
Q3
Sell
-120
Closed -$11K 4013
2016
Q2
$11K Buy
+120
New +$11K ﹤0.01% 3098
2015
Q2
Sell
-69
Closed -$34K 4766
2015
Q1
$34K Buy
+69
New +$34K ﹤0.01% 3982